SSY Stock: SunLink Health Systems, Inc. Stock Price, Analysis & Insights
Get live ssy stock price $1.11, comprehensive SunLink Health Systems, Inc. stock analysis, charts, news, and expert forecast. Real-time ssy stock data and investment insights.
Loading chart...
Company Overview
SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit; and a 66-bed extended care and rehabilitation center. This segment also provides information technology services; and owns unimproved lands. The Pharmacy segment offers institutional and non-institutional pharmacy services; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.
Company Information
- CEO
- Robert M. Thornton Jr.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Employees
- 1376
Contact Information
- Address
- 900 Circle 75 Parkway
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
SunLink Health Systems, Inc. operates in the Medical - Pharmaceuticals industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Robert M. Thornton Jr., the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Pharmaceuticals model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
SunLink Health Systems, Inc. competes in the Medical - Pharmaceuticals within the broader Healthcare. With 7.9 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange Arca, SunLink Health Systems, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating SunLink Health Systems, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for SunLink Health Systems, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for SunLink Health Systems, Inc.
- ⚠Investors should consider how SunLink Health Systems, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
7.85M
P/E Ratio
-2.86
Beta
1.15
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 7.85M market capitalization
- Trading Volume: 225.73K shares traded today
- Price Range: 52-week range of $0.62 - $1.91
- Exchange: Listed on New York Stock Exchange Arca
Financial Metrics
Market Analysis for SunLink Health Systems, Inc.
SunLink Health Systems, Inc. (SSY) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. With a current market capitalization of 7.85M, the company represents a significant player in its market. The stock is currently trading at $1.11 with a positivedaily change of 16.15%.
The company's 1376 employee base and presence on the New York Stock Exchange Arcaexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -2.86, beta of 1.15, and 52-week price range from $0.62 to $1.91when evaluating investment opportunities.
Why Invest in SunLink Health Systems, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange Arca)
- • Experienced leadership under Robert M. Thornton Jr.
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.